COMP <GO>
GD vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
General Dynamics Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: GD 10
— TMO 4
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: GD
LAST: $372.59 (+0.48%) • MKT CAP: $100.33B
balance-sheet
4.65
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GD VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GD | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.00% | 9.30% | +4.70 | GD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.6x | 30.4x | -13.80 | GD | /valuation <GO> |
| Free Cash Flow Yield | 3.95% | 2.40% | +1.55 | GD | /fcf-yield <GO> |
| Operating Margin | 10.20% | 17.40% | -7.20 | TMO | /operating-margins <GO> |
| Net Profit Margin | 8.00% | 15.10% | -7.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 10.10% | 3.90% | +6.20 | GD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.59% | 0.24% | +1.35 | GD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 4.65 | 4.50 | +0.15 | GD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | GD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.70% | +0.20 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.4 | 59.1 | +14.27 | GD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 0.94 | +0.05 | GD | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.1x | 36.3x | -14.20 | GD | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $100.33B | $262.22B | -$161.89B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GD REV | TMO REV | GD GROSS % | TMO GROSS % | GD FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $52.55B | $44.56B | 44.0% | 44.0% | $3.96B | $6.29B |
| FY 2024 | $47.72B | $42.88B | 44.0% | 44.0% | $3.20B | $7.27B |
| FY 2023 | $42.27B | $42.86B | 44.0% | 44.0% | $2.81B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GD // BETA 0.99
TMO // BETA 0.94